切换至 "中华医学电子期刊资源库"

中华眼科医学杂志(电子版) ›› 2022, Vol. 12 ›› Issue (02) : 105 -109. doi: 10.3877/cma.j.issn.2095-2007.2022.02.008

病例报告

葡萄膜炎-青光眼-前房出血综合征一例
宋春玲1, 刘冬梅2, 刘艳2, 沙芳2, 孙璇2, 郭大东3, 杜秀娟2,()   
  1. 1. 250002 济南,山东中医药大学附属眼科医院青光眼科;266323 同济大学附属东方医院胶州医院眼科;264000 滨州医学院2019级硕士研究生
    2. 250002 济南,山东中医药大学附属眼科医院青光眼科;250002 济南,山东省眼病防治研究院
    3. 250002 济南,山东省眼病防治研究院
  • 收稿日期:2021-12-11 出版日期:2022-04-28
  • 通信作者: 杜秀娟
  • 基金资助:
    国家自然基金项目(81873163); 山东省自然科学基金项目(ZR2020KC024); 山东省医药卫生科技发展计划项目(2019WS566)

One case of uveitis-glaucoma-hyphema

Chunling Song1, Dongmei Liu2, Yan Liu2   

  • Received:2021-12-11 Published:2022-04-28
引用本文:

宋春玲, 刘冬梅, 刘艳, 沙芳, 孙璇, 郭大东, 杜秀娟. 葡萄膜炎-青光眼-前房出血综合征一例[J/OL]. 中华眼科医学杂志(电子版), 2022, 12(02): 105-109.

Chunling Song, Dongmei Liu, Yan Liu. One case of uveitis-glaucoma-hyphema[J/OL]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2022, 12(02): 105-109.

图3 患者右眼术后的检查结果 图3A示术后裂隙灯显微镜检查,可见右眼角膜透明,房水闪辉(-),房水细胞(-),瞳孔类圆,直径3.5 mm,光反射(+),人工晶状体正位;图3B示术后全视野计检查,可见右眼视野向心性缩小
[1]
Ellingson TF. The uveitis-glaucoma-hyphema syndrome associated with the Mark Ⅷ anterior chamber lens implant[J]. Am Intra-Ocular Implant Society J, 1978, 4(2): 50-53.
[2]
Du Y, Zhu X, Yang J, et al. Uveitis-glaucoma-hyphema syndrome with sclera-fixed posterior-chamber two-haptic intrao-cular lens in a highly myopic eye: a case report[J]. BMC Ophthalmology, 2020: 1-5.
[3]
Armonaite L, Behndig A. Seventy-one cases of uveitis-glaucoma-hyphaema syndrome[J]. Acta Ophthalmol, 2021, 99(1):69-74.
[4]
季樱红,荣先芳,卢奕.左眼葡萄膜炎-青光眼-前房积血综合征1例 [J].中国眼耳鼻喉科杂志20212(21):23-27.
[5]
Apple DJ, Mamlis N, Loftfield K, et al. Complications of intraocular lenses: a historical and histopathological review[J]. Surv Ophthalmol, 1984, 29: 1-54.
[6]
Chan TC, Lok JK, Jhanji V, et al. Intraocular lens explantation in Chinese patients: different patterns and different responses[J]. Int Ophthalmol, 2015, 35(5): 679-684.
[7]
Dalton M, Cheung A. UGH rare, but potentially devastating complication[J]. Ophthalmlogy Times, 2016, 30(2): 23-26.
[8]
Lin CJ, Tan CY, Lin SY, et al. Uveitis-glaucoma-hyphaema syndrome caused by posterior chamber intraocular lens-a rare complication in pediatric cataract surgery[J]. Ann Ophthalmol, 2008, 40(3-4): 183-184.
[9]
Capitena YCE, St-Peter DM, Ertel MK, et al. Hydrus Microstent malposition with uveitis-glaucoma-hyphema syndrome[J]. Am J Ophthalmol Case Rep, 2022, 9(25): 101405.
[10]
Danny M, Michael AP, Joshua HO. Yoga-induced uveitis glaucoma hyphema syndrome[J]. Digit J Ophthalmol, 2020, 26(4): 46-48.
[11]
Ellingson FT. Complications with the Choyce Mark Ⅷ anteriorchamber lens implant (uveitis-giaucoma-hyphema)[J]. Am Intra-Ocular Implant Soc J, 1977, 3: 199-201.
[12]
Zhang L, Christopher T, Hood JP, et al. Mechanismsfor in-the-bag uveitis-glaucoma-hyphema syndrome [J].J Cataractefract Surg, 2014, 40: 490-492.
[13]
Piette S, Canlas OATran HV, et al. Ultrasound biomicroscopyin uveitis-glaucoma-hyphema syndrome[J]. Am J Ophthalmol, 2002, 133(6): 839-841.
[14]
Mostafavi D, Nagel D, Danias J. Haptic-induced postoperative complications. Evaluation using ultrasound biomicroscopy[J]. Can J Ophthalmol, 2013, 48(6): 478-481.
[15]
Kirk KR, Werner L, Jaber R, et al,Pathologic assessment of complications with asymmetric or sulcus fixation of square-edged hydrophobic acrylic intraocular lenses [J].Ophthalmology, 2012, 119: 907-913.
[16]
Lima BR, Pichi F, Hayden BC, et al. Ultrasound biomicroscopy in chronic pseudophakic ocular inflammation associated with misplaced intraocular lens haptics[J]. Am J Ophthalmol, 2014157(4): 813-817.
[17]
Durr GM, Ahmed IIK. Intraocular lens complications: decentration, uveitis-glaucoma-hyphema syndrome, opacification, and refractive surprises[J].Ophthalmology, 2021, 128(11): e186-e194.
[18]
Badakere SV, Senthil S, Turaga K, et al. Uveitis-glaucoma-hyphaema syndrome with in-the-bag placement of intraocular lens[J]. BMJ Case Rep, 2016, 11(1): 12-13.
[19]
Zhang L, Hood CT, Vrabec JP, et al. Mechanisms for in-the-bag uveitis-glaucoma-hyphema syndrome[J]. J Cataract Refract Surg, 2014, 40(3): 490-492.
[20]
Hou A, Hasbrook M, Crandall D. A case of uveitis-hyphema-glaucoma syndrome due to EX-PRESS glaucoma filtration device implantation[J]. J Glaucoma, 2019, 8(10): 159-161.
[21]
Cheung AY, Price JM, Hart JCJ. Late-onset uveitis-glaucoma-hyphema syndrome caused by Soemmering ring cataract[J]. Can J Ophthalmol, 2019, 54(4): 445-450.
[22]
Hanh M, Nguyen T. Uveitis-glaucoma-hyphaema syndrome[M]. Boston: New England Medical Center Grand Rounds, Tufts University, 1987.
[23]
Yasser A, Khan YK, Pavlin CJ, et al. Uveitis-glaucoma-hyphema syndrome after handmade, anterior chamber lens implantation[J]. J Cataract Refract Surg, 1997, 23: 1414-1417.
[24]
Alniemi ST, Amin SR, Sculley L, et al. Ultrasound Biomicroscopy in pseudophakic patients with unexplained recurrent hyphema or vitreous hemorrhage[J]. Semin Ophthalmol, 2018, 33(2): 260-264.
[25]
Alfaro-Juárez A, Vital-Berral C, Sánchez-Vicente JL, et al. Uveitis-glaucoma-hyphaema syndrome associated with recurrent vitreous hemorrhage[J]. Arch Soc Esp Oftalmol, 2015, 90(8): 392-394.
[26]
Sura AA, Reddy AK, Babic K, et al. Occult cause of uveitis-glaucoma-hyphema syndrome diagnosed during treatment with endocyclophotocoagulation (ECP) [J]. Am J Ophthalmol Case Rep, 2022, 12(26): 101537.
[27]
Wu N, Zhang H, Chen B, et al. A novel application of B-ultrasonography at various head positions in the diagnosis of untypical uveitis-glaucoma-hyphema(UGH) syndrome[J]. Medicine, 2019, 98(2): e13891.
[28]
Chi W, Yang P, Li B, et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease[J]. J Allergy Clin Immunol, 2007, 119(5): 1218-1224.
[29]
Zhang L, Wan F, Song J, et al. Imbalance between Th17 cells and regulatory T cells during monophasic experimental autoimmune uveitis[J]. Inflammation, 2016, 39(1): 113-122.
[30]
Zhou ZY, Chen SL, Shen N, et al. Cytokines and Behcet′s disease[J]. Autoimmun Rev, 2012, 11(10): 699-704.
[31]
Sota J, Cantarini L, Vitale A, et al. Long-term outcomes of Behcet′s syndrome-related uveitis: a monocentric Italian experience[J/OL]. MediatorsInflamm, 2020: 6872402.
[32]
Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Behcet′s syndrome[J]. Ann Rheum Dis, 2018, 77(6): 808-818.
[33]
Levy-Clarke G, Jabs DA, Read RW, et al. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders[J]. Ophthalmology, 2014, 121(3): 785-796.
[34]
Smit D, Meyer D, Maritz J, et al. Polymerase chain reaction and goldmann-witmer coefficient to examine the role of epstein-barr virus in uveitis[J]. Ocul Immunol Inflamm, 2019, 27(1): 108-113.
[35]
Iddawela D, Ehambaram K, Bandara P. Prevalence of toxocara antibodies among patients clinically suspected to have ocular toxocariasis: A retrospective descriptive study in Sri Lanka[J]. BMC Ophthalmol, 2017, 24, 17(1): 50.
[36]
Mahalakshmi B, Therese KL, Madhavan HN, et al. Diagnostic value of specific local antibody production and nucleic acid amplification technique-nested polymerase chain reaction (nPCR) in clinically suspected ocular toxoplasmosis comparative study[J].Ocul Immunol Inflamm, 2006, 14(2): 105-112.
[37]
Durand ML. Bacterial and fungal endophthalmitis[J]. Clin Microbiol Rev, 2017, 30(3): 597-613.
[38]
Bardoloi N, Sarkar S, Burgute PS, et al. Capsular tension ring assisted phacoemulsification of morgagniancataract[J]. Indian J Ophthalmol, 2021, 69(7): 1781-1785.
[39]
Rech L, Heckler L, Damji KF. Serial intracameral bevacizumab for uveitis-glaucoma-hyphema syndrome: a case report[J]. Can J Ophthal, 2014, 49: e160-e1602.
[40]
孙世然,王首雁.人工晶状体植入术后葡萄膜炎-青光眼-前房积血综合征的临床分析[J]. 临床眼科杂志201725(2):104-108.
[41]
Bodh SA, Kumar V, Raina UK, et al. Inflammatory glaucoma[J]. Oman J Ophthalmol, 2011, 4(1): 3-9.
[42]
Singh H, Modabber M, Safran SG, et al. Laser iridotomy to treat uveitis-glaucoma-hyphema syndrome secondary to reverse pupillary block in sulcus-placed intraocular lenses: case series[J]. J Cataract Refract Surg, 2015, 41(10): 2215-2223.
[43]
Sousa DC, Leal I, Faria MY, et al. A rare manifestation of uveitis-glaucoma-hyphema syndrome[J]. J Curr Glaucoma Pract, 2016, 10(2): 76-78.
[44]
Wintle R, Austin M. Pigment dispersion with elevated intraocular pressure after AcrySof intraocular lens implantation in the ciliary sulcus[J]. J Cataract Refract Surg, 2001, 27(4): 642-644.
[45]
Foroozan R, Tabas JG, Moster ML. Recurrent microhyphema despite intracapsular fixation of a posterior chamber intraocular lens[J]. J Cataract Refract Surg, 2003, 29(8): 1632-1635.
[46]
钱立峰,杨凯转,赵晓金,等.三点固定人工晶体睫状沟悬吊术临床观察[J]. 中华眼外伤职业眼病杂志201739(3):226-228.
[47]
陈桂英,唐耀冰,侯明佳. 人工晶状体睫状沟悬吊固定术治疗外伤眼的效果观察[J]. 中华眼外伤职业眼病杂志201739(7):520-522.
[48]
陈丽,刘思伟,刘明,等. 无囊膜支持眼巩膜内无缝线人工晶状体固定术[J]. 眼科新进展201131(11):1065-1067.
[49]
Takayama K, Akimoto M, Taguchi H, et al. Transconjunctival suture-less intrascleral intraocular lens fixation using intrascleral tunnels guided with catheter and 30-gauge needles[J]. Br J Ophthalmol, 2015, 99(11): 1457-1459.
[50]
Jasinskas V, Vaiciuliene R, Varoniukaite A, et al. Novel microsurgical management of uveitis-glaucoma-hyphema syndrome[J]. Int Ophthalmol, 2019, 39(7): 1607-1612.
[51]
Walland MJ. Uveitis-glaucoma-hyphaema syndrome treated with local laser iridoplasty[J]. Clin Exp Ophthal, 2017, 45: 647-648.
[52]
Liu Z, Zhang F, Wen Y, et al. Diode laser transscleral cyclo-photocoagulation for uveitis-glaucoma-hyphema syndrome: A case report[J]. Medicine, 2020, 99(7): 1-3.
[53]
Hermoso-Fernández FM, Gonzalez-Gallardo C, Cruz-Rojo M, et al. Retinal detachment in UGH Symdrome after cataract surgery[J]. Rom J Ophthalmol, 2021, 65(4): 395-398.
[54]
Razeghinejad MR, Havens SJ. largecapsulorhexis related uveitis-glaucoma-hyphema syndrome managed by intraocular lens implant exchange and gonioscopy assisted transluminal trabeculotomy[J]. J Ophthalmic Vis Res, 2019, 14(2): 215-218.
[55]
Elhusseiny AM, Lee RK, Smiddy WE. Surgical management of uveitis-glaucoma-hyphema syndrome[J]. Int J Ophthalmol, 2020, 13(6): 935-940.
No related articles found!
阅读次数
全文


摘要